Listen
Newsletters
Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Home
Bias Split
Public Figures
Controversies
Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters
Sign Up!
Sign Up Now!
About
Contact Us
Newsletter Archive
Media
FAQ
Glossary
Privacy Policy
© 2025 Improve the News Foundation. All rights reserved.
Version 6.15.0
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.15.0
HIV
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use recommended approval of lenacapavir, a twice-yearly injectable drug for HIV prevention, on Friday.
EU Regulator Backs Twice-Yearly HIV Prevention Injection
+5
JUL 26
JUL 26
FDA Approves Biannual HIV Prevention Shot
+3
JUN 18
JUN 18
Scientists Cut Out HIV DNA From Infected Cells
+6
MAR 24
MAR 24
Study: Highly-Affordable 'Vaccine-Like' HIV Drug Possible
+1
MAR 24
MAR 24
UN: AIDS Response 'Under Threat' Due to Stigmas
+7
MAR 24
MAR 24
Show More